99% Savings - Buy Just @1 Rs X
Gemone, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Bronchitis. Gemone also has some secondary and off-label uses. These are listed below.
The right dosage of Gemone depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Gemone include Nausea or vomiting, Diarrhoea, Dizziness. Besides the aforementioned side effects, there are other adverse effects of Gemone as well, which are listed below. Usually, these side effects of Gemone go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Gemone's effect is Moderate during pregnancy and Severe for lactating mothers. In addition, Gemone's effects on the liver, heart and kidney are discussed below in the Gemone related warnings section.
Gemone can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Gemone in conditions like Myasthenia Gravis (MG), Heart Disease, Tendon Injury (Tendinopathy). The section on Gemone contraindications lists all such conditions.
Drug reaction of Gemone with other medicines has been reported. See below for a complete list.
In addition to these precautions, you may also note that Gemone is not safe while driving, and is is not addictive in nature.
Gemone is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Gemone safe for pregnant women?
Gemone may have some side effects during pregnancy. Pregnant women should discontinue the use of Gemone, and talk to their doctor, if they notice any discomfort.
Is the use of Gemone safe during breastfeeding?
Taking Gemone may lead to serious side effects if you are breastfeeding. Gemone should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Gemone on the Kidneys?
Gemone has very mild side effects on the kidneys.
What is the effect of Gemone on the Liver?
Gemone is completely safe for the liver.
What is the effect of Gemone on the Heart?
Side effects of Gemone rarely affect the heart.
Gemone should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Gemone unless your doctor advises you to do so -
Is this Gemone habit forming or addictive?
Gemone is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
After taking Gemone, you should not drive or work on any heavy machine, as Gemone can make you drowsy.
Is it safe?
Gemone is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, the use of Gemone in mental disorders is not effective.
Interaction between Food and Gemone
Taking Gemone with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Gemone
Information about the interaction of Gemone and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Factive® (gemifloxacin mesylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584